Latest 5 articles from heartwire
- Sen Grassley questions top medical schools about ghostwriting
Nov 20, 2009 13:15 EDT - Stroke incidence related to PCI steady over 15 years
Nov 20, 2009 13:00 EDT - ALLHAT investigators report 10-year follow-up and stand by diuretics as first step antihypertensive treatment
Nov 19, 2009 14:00 EDT - Oral anticoagulants REDEEMed? Daily dabigatran "safe" with dual antiplatelets after MI
Nov 19, 2009 11:00 EDT - EFFECT: Public reporting of hospital performance improves quality of care?
Nov 19, 2009 10:00 EDT
ArchivesArchives
Also from theheart.org
About The Bob Harrington Show
Take part in this new interactive series! Start by joining Dr Harrington and his guests for a frank and insightful review of the latest clinical trials, events and education in the realm of cardiology. Then it’s your turn: share your thoughts by writing them in the comments box (at left) or by phoning our studios and leaving a voice message: 1-866-996-5440. There’s a show posted every two weeks, why not join in? We value the diverse opinions of our readership that includes you and look forward to a hearty exchange!
About Dr Robert A Harrington
Dr Robert A Harrington is a Professor of Medicine at Duke University, Director of the Duke Clinical Research Institute, and a practicing interventional cardiologist. He is the recipient of an NIH Roadmap contract to investigate “best practices” among clinical trial networks, and is a Fellow of the ACC, AHA, SCAI, and American College of Chest Physicians. In addition, he currently serves as a member of the FDA Cardiovascular and Renal Drugs Advisory Committee and is a member of the NHLBI’s study section for clinical trials. A member of the ACC’s Board of Trustees, Dr Harrington chaired the ACC 2006 Annual Scientific Sessions.